TECHWIRE 30
(CIX: WRAL30)  1,112.74  down arrow-15.07  (-1.34 %)  Updated: 08:10 PM EST, Jan 30 2015
(NQ: Apple)  117.16  down arrow-1.74  (-1.46 %)  Updated: 08:10 PM EST, Jan 30 2015
(NY: QUINTILES)  60.50  down arrow-1.26  (-2.04 %)  Updated: 06:40 PM EST, Jan 30 2015
(OP: BASF SE)  89.56  down arrow-0.76  (-0.84 %)  Updated: 05:20 PM EST, Jan 30 2015
(NQ: BioCryst)  10.18  down arrow-0.5  (-4.68 %)  Updated: 08:10 PM EST, Jan 30 2015
(NQ: BioDelivery)  13.10  down arrow-0.53  (-3.89 %)  Updated: 08:10 PM EST, Jan 30 2015
(NQ: CEMP)  27.74  down arrow-0.23  (-0.82 %)  Updated: 08:10 PM EST, Jan 30 2015
(NQ: Cisco Systems)  26.37  down arrow-0.86  (-3.14 %)  Updated: 08:10 PM EST, Jan 30 2015
(NQ: Cree)  35.36  down arrow-0.39  (-1.09 %)  Updated: 08:10 PM EST, Jan 30 2015
(NQ: DARA)  0.84  down arrow-0.02  (-2.34 %)  Updated: 08:10 PM EST, Jan 30 2015
(NY: EMC CORPORATION)  25.93  down arrow-0.47  (-1.78 %)  Updated: 06:40 PM EST, Jan 30 2015
(NQ: Extreme Networks)  2.94  down arrow-0.1  (-3.29 %)  Updated: 08:10 PM EST, Jan 30 2015
(NQ: FB)  75.91  down arrow-2.09  (-2.68 %)  Updated: 08:10 PM EST, Jan 30 2015
(NY: GLAXOSMITHKLINE)  44.00  down arrow-1.16  (-2.57 %)  Updated: 06:40 PM EST, Jan 30 2015
(NQ: GOOG)  534.52  up arrow+23.86  (4.67 %)  Updated: 08:10 PM EST, Jan 30 2015
(NY: IBM)  153.31  down arrow-2.17  (-1.4 %)  Updated: 06:40 PM EST, Jan 30 2015
(NY: LH)  114.78  down arrow-1.34  (-1.15 %)  Updated: 06:40 PM EST, Jan 30 2015
(OP: Lenovo Group)  25.64  down arrow-0.22  (-0.85 %)  Updated: 05:20 PM EST, Jan 30 2015
(NY: MRK)  60.28  down arrow-1.81  (-2.92 %)  Updated: 06:40 PM EST, Jan 30 2015
(NQ: Microsoft Corp)  40.40  down arrow-1.61  (-3.83 %)  Updated: 08:10 PM EST, Jan 30 2015
(NQ: NTAP)  37.80  down arrow-0.26  (-0.68 %)  Updated: 08:10 PM EST, Jan 30 2015
(NY: NOVARTIS AG)  97.40  down arrow-1.76  (-1.77 %)  Updated: 06:40 PM EST, Jan 30 2015
(OP: Novozymes A/S)  45.65  up arrow+0.08  (0.18 %)  Updated: 05:20 PM EST, Jan 30 2015
(NY: PFIZER)  31.25  down arrow-0.58  (-1.82 %)  Updated: 06:40 PM EST, Jan 30 2015
(NQ: Pozen)  6.91  down arrow-0.17  (-2.4 %)  Updated: 08:10 PM EST, Jan 30 2015
(NY: RED HAT)  63.79  down arrow-1.96  (-2.98 %)  Updated: 06:40 PM EST, Jan 30 2015
(NQ: BBRY)  10.15  down arrow-0.1  (-0.98 %)  Updated: 08:10 PM EST, Jan 30 2015
(NQ: Salix)  134.67  down arrow-0.47  (-0.35 %)  Updated: 08:10 PM EST, Jan 30 2015
(NQ: SQI)  14.22  down arrow-0.04  (-0.28 %)  Updated: 08:10 PM EST, Jan 30 2015

Posts tagged “Duke”

Updated May 5, 2014

Premium Lock Veteran tech transfer exec leaves UVA, returning to NC roots

W. Mark Crowell, a veteran executive who led technology transfer efforts at UNC-CH, NCSU and Duke, is returning to the Triangle. Crowell is stepping down as executive director of the innovation program at the University of Virginia and plans to become a consultant based in Chapel Hill.

W. Mark Crowell W. Mark Crowell

April 16, 2014

Premium Lock Duke students launch world's first free mobile lottery

ExitEvent ExitEvent news: A new app gives lotto-players a free chance to walk away with a jackpot. ExitEvent's Laura Baverman has the details.

Updated April 10, 2014

Premium Lock Triangle ultra-fast Internet group backs AT&T plan

The race to be first to bring gigabit-speed Internet access across the Triangle and Triad may be won by AT&T, not Time Warner Cable or Google Fiber. The North Carolina Next Generation Network consortium says it is recommending that six city governments approve AT&T's proposal. However, the group is not precluding other companies from the project.

Service area as spelled out for NC NGN in RFP Service area as spelled out for NC NGN in RFP

April 10, 2014

Premium Lock NCNGN issues full statement about AT&T network proposal

NC NGN Early Thursday, the North Carolina Next Generation Network consortium issued a full statement explaining why it is recommending that six cities in the Triangle and the Triad "enthusiastically approved" support for AT&T's proposal to create an ultra-fast Internet network for the region.

Updated February 27, 2014

Premium Lock Startups put some 'wow' in CED Life Science Conference

DNA    Five new ventures, including three kickstarted in part with loans from the N.C. Biotechnology Center, make their pitches at the kickoff of the annual CED Life Science conference in Raleigh.

Updated February 20, 2014

Premium Lock NC Next Generation Network welcomes Google news but pushes ahead with own agenda

The people spearheading the NCNGN project are pushing ahead with their own plans even as they welcome the news that a Google Fiber network could be headed to the Triangle. "This is great news for the region, but this is still preliminary and our efforts are still continuing," said Elise Kohn

Service area as spelled out for NC NGN in RFP Service area as spelled out for NC NGN in RFP

February 19, 2014

Premium Lock Duke Health chief to head Institute of Medicine

Duke Health Dr. Victor Dzau, who serves as president and chief executive of Duke University Health System, has been named as the next president of the Institute of Medicine, which plays a lead role in advising Congress on health matters.

Updated January 20, 2014

Premium Lock Duke prof awarded $500K for osteoarthritis research

Arthritis  Dr. Farshid Guilak will use the Arthritis Foundation grant to research new drugs and stem cell therapies for osteoarthritis over the next five years at Duke University's School of Medicine.

Updated December 31, 2013

Premium Lock Argos files for $60M IPO to finance cancer immunotherapy trial

Nearly two years after pulling back on IPO plans, Argos Therapeutics is again seeking to go public to finance phase III clinical trials for its kidney cancer immunotherapy. Read more about Argos' plans.

Argos' immunotherapy process Argos' immunotherapy process

December 11, 2013

Premium Lock Oxygen Bio picks DCRI for late-stage clinical trial on heart drug

Oxygen Biotherapeutics Oxygen Biotherapeutics is prepping to start late-stage clinical trials on a drug candidate that could treat low cardiac outpput syndrome and the company is tapping the cardiac surgery trials experience of the Duke Clinical Research Institute to do it.

Updated December 10, 2013

Premium Lock Duke lands $2.9M Gates grant for HIV vaccine project

HIV AIDS research  The Bill & Melinda Gates Foundation is backing a three-year effort at Duke University to develop a vaccine to combat HIV. The vaccine candidate mimics a virus particle.

Updated November 19, 2013

Premium Lock 'Hack Duke' - an 'off the charts' event for tech creators

Organized just this semester, the weekend event draws student inventors from across the southeast. Top prize goes to a team that turns sign language into speech through use of an amazing glove. Duke senior Dennis Li helped put the event together, and Adam Klein of The American Underground gives the tech showcase a big thumbs up.

October 30, 2013

Premium Lock Aerie Pharma closes IPO, raising $68.4M

Aerie Pharmaceuticals Glaucoma drug developer Aerie Pharmaceuticals (NASDAQ:AERI) closed its initial public offering of stock Wednesday raising a total of $68.4 million that the company plans to use for clinical trials.

Updated October 25, 2013

Premium Lock Aerie Pharma cuts stock price, adds shares for $67M IPO; Chimerix sells more stock

Aerie Pharmaceuticals Aerie Pharmaceuticals' $67 million IPO was priced at $10 per share, well below the $12 to $14 per share range the company had previously set. Read more about the offering.

September 27, 2013

Premium Lock Regado Biosciences cutting jobs at Durham operation

Regado's pipeline The drug development firm, which is built around technology developed at Duke University and recently went public, is cutting jobs to save cash.

September 13, 2013

Premium Lock UNC awarded $5.8M to lead research project on cloud cybersecurity

UNC is leading four other institutions in conducting cybersecurity in cloud computing. Read more about the federally funded research project.

Network security   Network security

Updated September 4, 2013

Premium Lock Duke's Dan Ariely cracks Bloomberg's 'Most Influential' list

What does best-selling author and Duke professor Dan Ariely have in common with some of the best-known names in business, economics and government? He's on the latest "50 Most Influential" list from Bloomberg Markets Magazine.

Dan Ariely's latest book Dan Ariely's latest book

Updated August 30, 2013

Premium Lock Social media spending is up but showing results proves to be a tough cookie

Corporations wants to jump onto the social media bandwagon. But companies so far have yet to see much bang for their buck, according to a survey of marketing executives conducted by Duke University.

How companies view the impact of social media How companies view the impact of social media

Updated August 28, 2013

Premium Lock NC's Next Generation Network project targets fall 2014 for rollout

The organizers of the North Carolina Next Generation Network project are wading through a larger than expected response from a variety of partnerships and firms that want to help build an ultra-high speed Internet project across the Triangle and Triad. The NCNGN project manager says the timeline for picking the builders is "fluid" but backers "hope the service will begin by the fourth quarter 2014." The full story is available to WRALTechWire Insiders

Service area as spelled out for NC NGN in RFP Service area as spelled out for NC NGN in RFP

Techwire Inside Partners
The Skinny: A Blog by Rick Smith